ACTIVE

Eqwal Charleroi

Export PDF

Financial year 2025 · closed on 30/09/2025

Net result

-234,9 k €

-185.3% YoY

Gross margin

1,2 M €

-18.9% YoY

Equity

478,6 k €

-32.9% YoY

Workforce

20,0 ETP

-10.3% YoY

What does Eqwal Charleroi do?

Eqwal Charleroi is a Public limited company incorporated in 1977. Its main activity is: Retail sale of medical and orthopaedic goods in specialised stores. Its registered office is in Fleurus. It employs on average 20,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0416.731.202

Incorporation

06/01/1977

Legal form

Public limited company

Registered office

Rue du Rabiseau(FL) 8
6220 Fleurus · WallonieSee on map

Contributed capital

62 000,00 €

Latest accounts

30/09/2025

Average workforce

20,0 ETP

Activities (NACE)

47740Retail sale of medical and orthopaedic goods in specialised stores· main 47741Retail sale of medical and orthopaedic goods in specialised stores 52320Warehousing and support activities for transportation

Joint committees (3)

12806
201
340

Signals

Solid equityGood liquidityHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	1,2 M €	-18.9%	1,5 M €	-8.4%	1,6 M €	-0.3%	1,6 M €	-11.8%	1,8 M €	+17.4%	1,6 M €	+1.8%	1,5 M €	+134%	657 k €	-2.7%	674,9 k €	-5.0%	710,5 k €	+17.0%	607,2 k €	-10.1%	675,1 k €	+17.6%	573,8 k €	-10.2%	639,1 k €	-4.9%	672,3 k €	+6.0%	634,3 k €	+22.6%	517,4 k €
EBITDA	-127,7 k €	-132%	400,1 k €	+1273%	29,1 k €	-13.5%	33,7 k €	-92.7%	463,2 k €	+175%	168,4 k €	+35.6%	124,1 k €	-17.6%	150,6 k €	+21.6%	123,9 k €	-10.9%	139 k €	+182%	49,3 k €	-76.1%	205,8 k €	+54.8%	133 k €	-41.1%	225,8 k €	+30.0%	173,7 k €	+35.5%	128,2 k €	+21.0%	105,9 k €
Operating result	-233,2 k €	-171%	330,1 k €	+1551%	-22,8 k €	+61.1%	-58,5 k €	-115%	378,3 k €	+648%	50,6 k €	+33.9%	37,7 k €	-43.5%	66,8 k €	+42.8%	46,8 k €	-32.6%	69,5 k €	+445%	-20,1 k €	-115%	132,4 k €	+69.5%	78,1 k €	-41.8%	134,2 k €	+40.5%	95,5 k €	+72.1%	55,5 k €	+0.3%	55,3 k €
Net result	-234,9 k €	-185%	275,5 k €	+642%	-50,8 k €	+30.1%	-72,7 k €	-127%	269,8 k €	+1642%	15,5 k €	+33.2%	11,6 k €	-72.6%	42,5 k €	+12.2%	37,9 k €	-18.3%	46,4 k €	+318%	-21,2 k €	-121%	99 k €	+68.2%	58,9 k €	-33.8%	88,9 k €	+12.2%	79,2 k €	+98.6%	39,9 k €	-10.0%	44,3 k €
Balance sheet
Equity	478,6 k €	-32.9%	713,6 k €	-16.8%	858,1 k €	-5.6%	908,9 k €	-7.4%	981,7 k €	+47.0%	667,8 k €	+0.1%	667,3 k €	-4.8%	700,6 k €	+1.8%	688,2 k €	-18.4%	843,3 k €	+3.7%	812,9 k €	-2.5%	834,2 k €	+6.0%	787,2 k €	+3.4%	761,3 k €	+9.1%	697,7 k €	+11.5%	626 k €	+6.8%	586,1 k €
Total assets	1,3 M €	-36.2%	2,1 M €	+5.2%	2 M €	-17.1%	2,4 M €	-2.0%	2,4 M €	+10.7%	2,2 M €	+1.3%	2,2 M €	+7.8%	2 M €	+4.4%	1,9 M €	-11.3%	2,2 M €	+22.6%	1,8 M €	+13.0%	1,6 M €	+2.2%	1,5 M €	-3.0%	1,6 M €	-0.2%	1,6 M €	+3.0%	1,5 M €	-7.0%	1,7 M €
Cash	134,5 k €	-44.8%	243,5 k €	-28.9%	342,3 k €	+289%	88 k €	-77.6%	393,7 k €	+446%	72,1 k €	+55.4%	46,4 k €	-16.3%	55,4 k €	+77.9%	31,1 k €	-18.5%	38,2 k €	+3.6%	36,8 k €	-52.9%	78,3 k €	+55.5%	50,3 k €	-33.1%	75,2 k €	+18.3%	63,6 k €	-11.5%	71,9 k €	+119%	32,8 k €
Debts	840,8 k €	-37.9%	1,4 M €	+22.3%	1,1 M €	-24.8%	1,5 M €	+1.9%	1,4 M €	-5.1%	1,5 M €	+1.5%	1,5 M €	+15.3%	1,3 M €	+6.6%	1,2 M €	-7.1%	1,3 M €	+39.5%	941,4 k €	+30.6%	720,7 k €	-0.1%	721,4 k €	-9.9%	800,4 k €	-7.5%	865,2 k €	-4.1%	902,3 k €	-14.3%	1,1 M €
Other
Workforce	20,0 ETP	-10.3%	22,3 ETP	-11.5%	25,2 ETP	-2.7%	25,9 ETP	+2.8%	25,2 ETP	-9.7%	27,9 ETP	-2.8%	28,7 ETP	+133%	12,3 ETP	+1.7%	12,1 ETP	-4.7%	12,7 ETP	+7.6%	11,8 ETP	+24.2%	9,5 ETP	+3.3%	9,2 ETP	-11.5%	10,4 ETP	-14.0%	12,1 ETP	-10.4%	13,5 ETP	+3.1%	13,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 30/09/2025 · 1 active · 28 ended

Active mandates

FINICOMA

Director · since 31 octobre 2023 · 0668.547.457

Represented by Jean-Pierre Mahé

Active

Ended mandates

ABSOlute Consulting

Director · since 01 avril 2022 · until 31 octobre 2023 · 0895.690.971

Represented by Olivier Beguin

Ended

ABSOlute Consulting

Director · since 01 avril 2022 · 0895.690.971

Represented by Olivier Beguin

Ended

CELLULOSE

Director · since 30 septembre 2020 · 0746.607.119

Represented by Jean-François Deltenre

Ended

TARS

Director · since 01 janvier 2020 · until 30 novembre 2022 · 0643.491.367

Represented by Benjamin Bullman

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/10/2024	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	30/09/2025	30/09/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	9 months	12 months	12 months	12 months	12 months
Filing date	13/04/2026	17/04/2025	17/10/2024	11/07/2023	18/07/2022	19/07/2021
General meeting	13/03/2026	31/03/2025	16/10/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/09/2025	13/03/2026	13/04/2026	French	PDF
Abridged model	30/09/2024	31/03/2025	17/04/2025	French	PDF
Abridged model	31/12/2023	16/10/2024	17/10/2024	French	PDF
Abridged model	31/12/2022	30/06/2023	11/07/2023	French	PDF
Abridged model	31/12/2021	30/06/2022	18/07/2022	French	PDF
Abridged model	31/12/2020	30/06/2021	19/07/2021	French	PDF
Abridged model	31/12/2019	22/05/2020	19/06/2020	French	PDF
Abridged model	31/12/2018	20/06/2019	26/06/2019	French	PDF
Abridged model	31/12/2017	25/06/2018	06/07/2018	French	PDF
Abridged model	31/12/2016	16/06/2017	11/07/2017	French	PDF
Abridged model	31/12/2015	27/05/2016	22/06/2016	French	PDF
Abridged model	31/12/2014	15/06/2015	07/07/2015	French	PDF
Abridged model	31/12/2013	17/06/2014	26/06/2014	French	PDF
Abridged model	31/12/2012	13/06/2013	04/07/2013	French	PDF
Abridged model	31/12/2011	29/06/2012	23/07/2012	French	PDF
Abridged model	31/12/2010	28/06/2011	12/07/2011	French	PDF
Abridged model	31/12/2009	28/06/2010	15/07/2010	French	PDF
Abridged model	31/12/2008	22/05/2009	29/06/2009	French	PDF
Abridged model	31/12/2007	23/05/2008	17/06/2008	French	PDF
Abridged model	31/12/2006	21/06/2007	23/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/09/2025 · 1 active · 28 ended

Active mandates

FINICOMA

Director · since 31 octobre 2023 · 0668.547.457

Represented by Jean-Pierre Mahé

Active

Ended mandates

ABSOlute Consulting

Director · since 01 avril 2022 · until 31 octobre 2023 · 0895.690.971

Represented by Olivier Beguin

Ended

ABSOlute Consulting

Director · since 01 avril 2022 · 0895.690.971

Represented by Olivier Beguin

Ended

CELLULOSE

Director · since 30 septembre 2020 · 0746.607.119

Represented by Jean-François Deltenre

Ended

TARS

Director · since 01 janvier 2020 · until 30 novembre 2022 · 0643.491.367

Represented by Benjamin Bullman

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates13/10/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DENOMINATION
PDF
Mandates28/05/2025
DEMISSIONS, NOMINATIONS
PDF
Other02/07/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - ASSEMBLEE GENERALE - ANNEE COMPTABLE
PDF
Mandates18/01/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates24/11/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
PDF
Mandates21/11/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates05/05/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates15/07/2022
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-234,9 k €↓
2025
Name changeEqwal Charleroi
2024
Annual accounts 2024275,5 k €↑
2023
Annual accounts 2023-50,8 k €↑
2022
Annual accounts 2022-72,7 k €↓
2021
Annual accounts 2021269,8 k €↑
2021
Name changeOrthopédie Toussaint
2018
Annual accounts 201815,5 k €↑
2017
Annual accounts 201711,6 k €↓
2016
Annual accounts 201642,5 k €↑
2015
Annual accounts 201537,9 k €↓
2014
Annual accounts 201446,4 k €↑
2013
Annual accounts 2013-21,2 k €↓
2012
Annual accounts 201299 k €↑
2011
Annual accounts 201158,9 k €↓
2010
Annual accounts 201088,9 k €↑
2009
Annual accounts 200979,2 k €↑
2008
Annual accounts 200839,9 k €↓
2007
Annual accounts 200744,3 k €
06/01/1977
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Eqwal Charleroi

Overview

What does Eqwal Charleroi do?

Trend over 17 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline